Docetaxel in the treatment of squamous cell carcinoma of the head and neck

Por Rapidis, Alexander, Sarlis, Nicholas, Lefebvre, Jean-Louis, Kies, Merrill
Publicado em 2008

EFFECT OF INDUCTION CHEMOTHERAPY ON SPEECH AND SWALLOWING FUNCTION IN PATIENTS WITH ORAL TONGUE CANCER

Por Barringer, Denise A., Hutcheson, Katherine A., Sturgis, Erich M., Kies, Merrill S., Lewin, Jan S.
Publicado em 2009

Cell-type dependent biomarkers expression in adenoid cystic carcinoma (ACC): biological and therapeutic implications

Por Bell, Diana, Roberts, Dianna, Kies, Merrill, Rao, Pulivarthi, Weber, Randal S., El-Naggar, Adel K.
Publicado em 2010

Genetic and Expression Analysis of HER-2 and EGFR Genes in Salivary Duct Carcinoma: Empirical and Therapeutic Significance

Por Williams, Michelle D., Roberts, Dianna B., Kies, Merrill S., Mao, Li, Weber, Randal S., El-Naggar, Adel K.
Publicado em 2010

MicroRNA Profiling of Salivary Adenoid Cystic Carcinoma: Association of miR-17-92 Upregulation with Poor Outcome

Por Mitani, Yoshitsugu, Roberts, Dianna B., Fatani, Hanadi, Weber, Randal S., Kies, Merrill S., Lippman, Scott M., El-Naggar, Adel K.
Publicado em 2013

Phase II Trial of Induction Chemotherapy Followed by Surgery for Squamous Cell Carcinoma of the Oral Tongue in Young Adults

Por Kies, Merrill S., Boatright, Dowin H., Li, Guojun, Blumenschein, George, El-Naggar, Adel K., Lewin, Jan S., Steinhaus, Ganene, Sturgis, Erich M.
Publicado em 2011

Detailed Genome-Wide SNP Analysis of Major Salivary Carcinomas Localizes Subtype-Specific Chromosome Sites and Oncogenes of Potential Clinical Significance

Por Zhang, Li, Mitani, Yoshitsugu, Caulin, Carlos, Rao, Pulivarthi H., Kies, Merrill S., Saintigny, Pierre, Zhang, Nianxiang, Weber, Randal S., Lippman, Scott M., El-Naggar, Adel K.
Publicado em 2013

Long-term Functional and Survival Outcomes after Induction Chemotherapy and Risk-Based Definitive Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Por Hutcheson, Katherine A., Lewin, Jan S., Holsinger, F. Christopher, Steinhaus, Ganene, Lisec, Asher, Barringer, Denise A., Lin, Heather Y., Villalobos, Sandra, Garden, Adam S., Papadimitrakopoulou, Vali, Kies, Merrill S.
Publicado em 2013

Novel MYBL1 gene rearrangements with recurrent MYBL1-NFIB fusions in salivary adenoid cystic carcinomas lacking t(6;9) translocations

Por Mitani, Yoshitsugu, Liu, Bin, Rao, Pulivarthi H., Borra, Vishnupriya J, Zafereo, Mark, Weber, Randal S., Kies, Merrill, Lozano, Guillermina, Futreal, P. Andrew, Caulin, Carlos, El-Naggar, Adel K.
Publicado no Clin Cancer Res (2015)

Phase 2 Study of Carboplatin, Docetaxel, and Bevacizumab as Frontline Treatment for Advanced Nonsmall-Cell Lung Cancer

Por William, William N., Kies, Merrill S., Fossella, Frank V., Liu, Diane D., Gladish, Gregory, Tse, Warner H., Lee, J. Jack, Hong, Waun K., Lippman, Scott M., Kim, Edward S.
Publicado no Cancer (2010)

Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21(st) century

Por Garden, Adam S, Kies, Merrill S, Morrison, William H, Weber, Randal S, Frank, Steven J, Glisson, Bonnie S, Gunn, Gary B, Beadle, Beth M, Ang, K Kian, Rosenthal, David I, Sturgis, Erich M
Publicado em 2013

Candidate Dosimetric Predictors of Long-Term Swallowing Dysfunction Following Oropharyngeal IMRT

Por Schwartz, David L., Hutcheson, Katherine, Barringer, Denise, Tucker, Susan L., Kies, Merrill, Holsinger, F. Christopher, Ang, K. Kian, Morrison, William H., Rosenthal, David I., Garden, Adam S., Dong, Lei, Lewin, Jan S.
Publicado em 2010

Phase I Study of Celecoxib with Concurrent Irinotecan, Cisplatin, and Radiation Therapy for Patients with Unresectable Locally Advanced Non-Small Cell Lung Cancer

Por Komaki, Ritsuko, Wei, Xiong, Allen, Pamela K., Liao, Zhongxing, Milas, Luka, Cox, James D., O’Reilly, Michael S., Chang, Joe Y., McAleer, Mary Frances, Jeter, Melenda, Blumenschein, George R., Kies, Merrill S.
Publicado em 2011

Postoperative Chemoradiotherapy and Cetuximab for High-Risk Squamous Cell Carcinoma of the Head and Neck: Radiation Therapy Oncology Group RTOG-0234

Por Harari, Paul M., Harris, Jonathan, Kies, Merrill S., Myers, Jeffrey N., Jordan, Richard C., Gillison, Maura L., Foote, Robert L., Machtay, Mitchell, Rotman, Marvin, Khuntia, Deepak, Straube, William, Zhang, Qiang, Ang, Kian
Publicado em 2014

High Survival and Organ Function Rates After Primary Chemoradiotherapy for Intermediate-Stage Squamous Cell Carcinoma of the Head and Neck Treated in a Multicenter Phase II Trial

Por Cohen, Ezra E.W., Haraf, Daniel J., List, Marcy A., Kocherginsky, Masha, Mittal, Bharat B., Rosen, Fred, Brockstein, Bruce, Williams, Rosalyn, Witt, Mary Ellyn, Stenson, Kerstin M., Kies, Merrill S., Vokes, Everett E.
Publicado no J Clin Oncol (2006)

Radiation Therapy (with or without neck surgery) for Phenotypic HPV- associated Oropharyngeal Cancer

Por Garden, Adam S., Fuller, Clifton D., Rosenthal, David I., William, William N., Gunn, Gary B., Beadle, Beth M., Johnson, Faye M., Morrison, William H., Phan, Jack, Frank, Steven J., Kies, Merrill S., Sturgis, Erich M.
Publicado no Cancer (2016)

Alterations Associated with Androgen Receptor Gene Activation in Salivary Duct Carcinoma (SDC) of Both Sexes: Potential Therapeutic Ramifications

Por Mitani, Yoshitsugu, Rao, Pulivarthi H., Maity, Sankar N., Lee, Yu-Chen, Ferrarotto, Renata, Post, Julian C., Licitra, Lisa, Lippman, Scott M., Kies, Merrill S., Weber, Randal S., Caulin, Carlos, Lin, Sue-Hwa, El-Naggar, Adel K.
Publicado no Clin Cancer Res (2014)

Advanced malignancies treated with a combination of the VEGF inhibitor bevacizumab, anti-EGFR antibody cetuximab, and the mTOR inhibitor temsirolimus

Por Liu, Xiaochun, Kambrick, Susan, Fu, Siqing, Naing, Aung, Subbiah, Vivek, Blumenschein, George R., Glisson, Bonnie S., Kies, Merrill S., Tsimberidou, Apostolia M., Wheler, Jennifer J., Zinner, Ralph G., Hong, David S., Kurzrock, Razelle, Piha-Paul, Sarina A.
Publicado no Oncotarget (2016)

Long-term, Prospective Performance of the M.D. Anderson Dysphagia Inventory in “Low-Intermediate Risk” Oropharyngeal Carcinoma after Intensity Modulated Radiation Therapy

Por Goepfert, Ryan P., Lewin, Jan S., Barrow, Martha P., Gunn, G. Brandon, Fuller, C. David, Beadle, Beth, Garden, Adam S., Rosenthal, David I., Kies, Merrill S., Papadimitrakopoulou, Vassiliki, Lai, Stephen Y., Gross, Neil, Schwartz, David L., Hutcheson, Katherine A.
Publicado no Int J Radiat Oncol Biol Phys (2016)

Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study

Por Cohen, Ezra E.W., Rosen, Lee S., Vokes, Everett E., Kies, Merrill S., Forastiere, Arlene A., Worden, Francis P., Kane, Madeleine A., Sherman, Eric, Kim, Sinil, Bycott, Paul, Tortorici, Michael, Shalinsky, David R., Liau, Katherine F., Cohen, Roger B.
Publicado no J Clin Oncol (2008)